Semaglutide in Psychiatry—Opportunities and Challenges
This Viewpoint discusses clinical trial results of glucagon-like peptide 1 receptor agonists for treating the weight gain and cardiovascular disease risk of psychiatric medications.
Authors
- Margaret Hahn (ORCID: https://orcid.org/0000-0001-8884-9946)
- Sri Mahavir Agarwal (ORCID: https://orcid.org/0000-0002-2705-5146)
Institutions
- Centre for Addiction and Mental Health (CA)
- University of Toronto (CA)
Publication Details
- Journal
- JAMA Psychiatry
- Published
- 2024-08-21
- DOI
- https://doi.org/10.1001/jamapsychiatry.2024.2412
- Citations
- 12
- Primary Topic
- Diabetes Treatment and Management
- Type
- article
- Field-Weighted Citation Impact
- 4.29